Melovox
Melovox is a smart pendant and companion app for vocal-volume regulation, targeting users with autism, Parkinson's, or professional vocal-strain needs.
The App DNA
What makes this app unique?
The device removes the background-noise sensitivity of smartphone-based monitors by placing the microphone directly near the wearer's vocal cords.
For Individuals with vocal volume regulation needs, including those on the autism spectrum, stage performers, and Parkinson's patients.
What does it look like?
Key features
Configures vibration alert sensitivity based on time of day or environment, facilitating institutional or clinical distribution.
Hardware pendant positions the microphone closer to the vocal cords than smartphone-based monitors, creating a brand moat.
Downloads and graphs vocal volume metrics to provide a longitudinal feedback loop for users.
How much does it cost?
The app is listed as free, but the hardware-dependent nature suggests a direct-to-consumer or medical device sales model.
Velocity
Dormant developmentShow more...
Melovox has not received a single update in over a year, with the last release occurring 397 days ago. The development history consists of only a single version, indicating a complete lack of ongoing maintenance or feature iteration. There is no evidence of active development, live operations, or bug-fix cycles.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Melovox
How's the Health & Fitness market?
Melovox occupies a specialized niche in the Health & Fitness category, relying on hardware-software integration to differentiate from software-only alternatives. The lack of public ratings or review volume suggests the app has not yet established a foothold in the broader consumer market.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Melovox
Where is it heading?
The vocal-regulation market is consolidating around software-based solutions that leverage existing wearable hardware. Melovox remains exposed due to its reliance on proprietary hardware and a lack of recent development activity.
- The thirteen-month development silence suggests the project is in maintenance-only mode, which erodes user trust in long-term device support.
The SWOT
- Hardware-software integration creates a high switching cost
- Threshold scheduling enables specialized clinical use cases
- Microphone proximity minimizes background noise sensitivity
- Clinical partnerships could unlock B2B distribution
Next best moves
Audit hardware-software connectivity because the 13-month update gap risks Bluetooth compatibility failure → maintain device utility
The counter-intuitive read
The hardware-first approach is a liability in the consumer market…
Read the full takeBottom line
Melovox addresses a specific clinical need through hardware-microphone placement, but the thirteen-month development silence threatens its long-term viability. Establishing a regular update cadence would address the technical risk currently preventing user adoption.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated